NASDAQ: MRVI Q3 2023 Financial Results Agenda 01 Welcome Deb Hart, Head of Investor Relations 02 Business Highlights Trey Martin, Chief Executive Officer 03 Financial Results Kevin Herde, Chief Financial Officer & Guidance 04 Q&A Session Trey Martin, Chief Executive Officer Kevin Herde, Chief Financial Officer Drew Burch, President, Nucleic Acid Production Becky Buzzeo, Chief Commercial Officer 2 ©2023 Maravai LifeSciences. This document and its contents are confidential and proprietary and are not to be sh ...